Rare Histological Variants of Prostate Adenocarcinoma: A National Cancer Database Analysis.
Recommended Citation
Bronkema C, Arora S, Sood A, Dalela D, Keeley J, Borchert A, Baumgarten L, Rogers CG, Peabody JO, Menon M, and Abdollah F. Rare Histological Variants of Prostate Adenocarcinoma: A National Cancer Database Analysis. J Urol 2020.
Document Type
Article
Publication Date
3-6-2020
Publication Title
The Journal of urology
Abstract
PURPOSE: The American Joint Committee on Cancer recognizes six rare histological variants of prostate adenocarcinoma. Our aim was to describe the contemporary presentation and overall survival of these rare variants.
MATERIALS AND METHODS: We examined 1345618 patients who were diagnosed with prostate adenocarcinoma, between 2004 and 2015, within the National Cancer Database. We focused on the following variants: mucinous, ductal, signet ring cell, adenosquamous, sarcomatoid, and neuroendocrine. Characteristics at presentation for each variant were compared with nonvariant prostate adenocarcinoma. Cox regression was used to study the impact of histological variant on overall mortality.
RESULTS: Few (0.38%) patients presented with rare-variant prostate adenocarcinoma. All variants had higher clinical tumor stage at presentation than nonvariant (all p<0.001). Metastatic disease was most common with neuroendocrine (62.9%), followed by sarcomatoid (33.3%), adenosquamous (31.1%), signet ring cell (10.3%), and ductal (9.8%), compared to 4.2% in nonvariant (all p<0.001). Metastatic disease in mucinous (3.3%) was similar to nonvariant (p=0.2). Estimated 10-year overall survival was highest in mucinous (78.0%), followed by nonvariant (71.1%), signet ring cell (56.8%), ductal (56.3%), adenosquamous (20.5%), sarcomatoid (14.6%) and neuroendocrine (9.1%). At multivariable analysis, mortality was higher in ductal (HR: 1.38; p<0.001), signet ring cell (HR: 1.53; p<0.01), neuroendocrine (HR: 5.72; p<0.001), sarcomatoid (HR: 5.81; p<0.001), and adenosquamous (HR: 9.34; p<0.001), as compared to nonvariant.
CONCLUSIONS: Neuroendocrine, adenosquamous, sarcomatoid, signet ring cell, and ductal variants more commonly present with metastases. All variants present with higher local stage than nonvariant. Neuroendocrine is associated with the worst, and mucinous with the best overall survival.
PubMed ID
32141804
ePublication
ePub ahead of print
First Page
101097
Last Page
101097
